Aethlon Medical (AEMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2015 | 03-2014 | 03-2013 | 03-2012 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,980 | -13,439 | -4,892 | -8,111 | -5,711 |
| Depreciation Amortization | 311 | 883 | 605 | 2,616 | 2,047 |
| Accounts receivable | -98 | 114 | 191 | -400 | N/A |
| Other Working Capital | -1,920 | 247 | 950 | 637 | 465 |
| Other Operating Activity | 3,637 | 10,057 | 1,047 | 3,417 | 1,231 |
| Operating Cash Flow | $-5,049 | $-2,139 | $-2,099 | $-1,841 | $-1,968 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -96 | N/A | -2 | -3 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -7 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -7 |
| Investing Cash Flow | $N/A | $-96 | $N/A | $-2 | $-9 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 415 | 400 | N/A | 1,694 | 1,105 |
| Common Stock Issued | 4,763 | 3,177 | 2,110 | 300 | 320 |
| Other Financing Activity | -524 | -217 | -30 | -23 | 500 |
| Financing Cash Flow | $4,655 | $3,360 | $2,080 | $1,971 | $1,925 |
| Beginning Cash Position | 1,250 | 125 | 144 | 16 | 68 |
| End Cash Position | 856 | 1,250 | 125 | 144 | 16 |
| Net Cash Flow | $-395 | $1,125 | $-19 | $128 | $-52 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,049 | -2,139 | -2,099 | -1,841 | -1,968 |
| Capital Expenditure | N/A | -96 | N/A | -2 | -3 |
| Free Cash Flow | -5,049 | -2,235 | -2,099 | -1,843 | -1,971 |